89283-43-2 Usage
Uses
Used in Pharmaceutical Industry:
N-(4-chlorothiazol-2-yl)acetamide is utilized as a key intermediate in the synthesis of thiazole-containing drugs. Its unique structure and properties make it a valuable compound for developing new pharmaceuticals with diverse therapeutic applications.
Used in Antibacterial and Antifungal Agents:
N-(4-chlorothiazol-2-yl)acetamide is studied for its potential as an antibacterial and antifungal agent. Its chemical structure allows it to target and inhibit the growth of various harmful microorganisms, making it a promising candidate for the development of new antimicrobial drugs.
Used in Anti-inflammatory and Analgesic Applications:
N-(4-chlorothiazol-2-yl)acetamide has also been investigated for its anti-inflammatory and analgesic properties. Its potential to alleviate inflammation and pain could contribute to the creation of novel therapeutic agents for the treatment of various inflammatory and painful conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 89283-43-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,2,8 and 3 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 89283-43:
(7*8)+(6*9)+(5*2)+(4*8)+(3*3)+(2*4)+(1*3)=172
172 % 10 = 2
So 89283-43-2 is a valid CAS Registry Number.
89283-43-2Relevant academic research and scientific papers
ORGANIC COMPOUNDS
-
Page/Page column 82, (2010/04/06)
The present invention relates to a compound of formula (I) (I) or a salt thereof, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase.
Organic Compounds
-
Page/Page column 79, (2009/07/10)
The present invention relates to compounds of formula I and its salts, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase.
